XML 134 R115.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Contingencies and commitments (NEUPOGEN Patent Litigation) (Details) - patent | Oct. 03, 2018 | Mar. 08, 2018 | Dec. 13, 2017
--- | --- | --- | ---
Adello NEUPOGEN Patent Litigation [Member] |  |  |
Gain Contingencies [Line Items] |  |  |
Number of patents allegedly infringed | 4 | 17 |
Apotex NEUPOGEN/Neulasta Patent Litigation [Member] |  |  |
Gain Contingencies [Line Items] |  |  |
Number of patents allegedly infringed |  |  | 1

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_GainContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of entity's patents that another entity has allegedly infringed. + References No definition available. + Details
Name: | us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_GainContingenciesByNatureAxis=amgn_AdelloNEUPOGENPatentLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_GainContingenciesByNatureAxis=amgn_ApotexNeupogenNeulastaPatentLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |